Wednesday - June 10, 2026
GSK Enters Agreement to Acquire Nuvalent Inc.
June 10, 2026
LONDON, England, June 10 -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release on June 9, 2026:

* * *

GSK enters agreement to acquire Nuvalent, Inc.

- Multi-product oncology deal for assets that have validated targets and aim to address efficacy and/or tolerability limitations of existing therapies

- Includes two late-stage, potential best-in-class ROS1 (zidesamtinib) and ALK (neladalkib) inhibitors f . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products